RE: Share split20 Jun 2022 17:47
from Halifax:
Demerger.
1 Haleon PLC (Haleon) share for each Existing GSK PLC (GSK) share held on 18th July 2022, being the Ex-entitlement Date
And
Consolidation of GSK shares at a rate yet to be determined, effective 19th July 2022.
On 23 June 2021 GSK confirmed its intention to separate its Consumer Healthcare business from the GSK Group to form Haleon plc, by way of a Demerger.
The Demerger and the Consolidation are subject to shareholder approval at the General Meeting to be held on 6th July 2022.
The Demerger is expected to become effective on 18th July 2022 and the New Haleon shares are expected to be received on or after 18th July 2022. Please note you will retain your holding of GSK plc shares.
The Book Cost of your original holding will be apportioned between the two companies according to their relative opening prices on the effective date of the Demerger.
The Haleon shares will commence dealing on the London Stock Exchange on 18th July 2022.
Following completion of the Demerger and listing of Haleon, GSK intends to effect a share Consolidation. The Consolidation rate will be announced shortly after the demerger is completed and is expected to become effective on 19th July 2022.
GSK have stated they will announce the Consolidation rate on Monday 18th July 2022 and for this to apply following the market closing at 430pm. We will endeavour to update your account as soon as possible after the market closes, and you will likely have fewer shares in GSK following the Consolidation.